Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Invested Capital (2022 - 2023)

Historic Return on Invested Capital for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.15%.

  • Mirum Pharmaceuticals' Return on Invested Capital rose 2700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.37% for FY2024, which is 1900.0% up from last year.
  • Mirum Pharmaceuticals' Return on Invested Capital amounted to 0.15% in Q3 2025, which was up 2700.0% from 0.24% recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Return on Invested Capital ranged from a high of 0.15% in Q3 2025 and a low of 2.12% during Q3 2021
  • Moreover, its 5-year median value for Return on Invested Capital was 0.8% (2022), whereas its average is 0.83%.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Return on Invested Capital crashed by -12200bps in 2021, and later soared by 12500bps in 2022.
  • Over the past 5 years, Mirum Pharmaceuticals' Return on Invested Capital (Quarter) stood at 1.93% in 2021, then surged by 59bps to 0.8% in 2022, then surged by 47bps to 0.42% in 2023, then increased by 9bps to 0.39% in 2024, then surged by 60bps to 0.15% in 2025.
  • Its Return on Invested Capital stands at 0.15% for Q3 2025, versus 0.24% for Q2 2025 and 0.34% for Q1 2025.